The mentioned above article was withdrawn by EIC descision.
e-ISSN 1726-6890
p-ISSN 1735-0328
Outline
Withdrawal Note of "Application of Cell-Based Assay Systems for the Early Screening ofHuman Drug Hepatotoxicity in the Discovery Phase of Drug Development"
Authors
1School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*Corresponding Author: School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: archive@ijpr.ir
Published online:Dec 21, 2025
Article type:Research Article
Received:May 20, 2022
Accepted:Dec 21, 2025
How to Cite:Archive I. Withdrawal Note of "Application of Cell-Based Assay Systems for the Early Screening ofHuman Drug Hepatotoxicity in the Discovery Phase of Drug Development". Iran J Pharm Res. 2005;4(4):e128254. doi:
Copyright
Copyright © 2005, Archive. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
21
Dec
2025
Withdrawn “Application of Cell-Based Assay Systems for the Early Screening ofHuman Drug Hepatotoxicity in the Discovery Phase of Drug Development”
IJPR Archive
Archive I. Withdrawn “Application of Cell-Based Assay Systems for the Early Screening ofHuman Drug Hepatotoxicity in the Discovery Phase of Drug Development”. Iran J Pharm Res. 2005;4(4):e128245. doi:
20
Nov
2010
Application of Proteomics Technologies in the Drug Development Process
Seyed Hassan Moghaddamnia
Moghaddamnia SH. Application of Proteomics Technologies in the Drug Development Process. Iran J Pharm Res. 2022;8(3):e128629. doi: https://doi.org/10.22037/ijpr.2010.802
4
May
2013
Can Natural Products be Used for Protection of the Liver?
Mohammad Hassan Pipelzadeh
Pipelzadeh MH. Can Natural Products be Used for Protection of the Liver?. Jundishapur J Nat Pharm Prod. 2013;8(2):53-54. doi: https://doi.org/10.17795/jjnpp-11816
31
Mar
2005
2 Published Abstracts in the field of Hepatitis
Seyed Moayed Alavian
Alavian S. 2 Published Abstracts in the field of Hepatitis. Hepat Mon. 2005;5(1):. doi:
20
Nov
2010
The Need to Establish a Common Base Line for the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets
Jalal Pourahmad
Pourahmad J. The Need to Establish a Common Base Line for the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets. Iran J Pharm Res. 2022;7(4):e128597. doi: https://doi.org/10.22037/ijpr.2010.771
Cited by
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 0
Last Update: 2 weeks ago
- Scopus by Title (Ref): 0
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 3 hours ago
- OpenAlex: 0
Last Update: 6 hours ago
- OpenCitations: 0
Last Update: 4 days ago
Comments
Number of Comments:0Indexed in
